A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Vividion Therapeutics, Inc.
Centre Oscar Lambret
Alterome Therapeutics, Inc.
Eisai Inc.
Cartography Biosciences
Coherus Oncology, Inc.
ViroMissile, Inc.
Replimune Inc.
Pfizer
Astellas Pharma Inc
AstraZeneca
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Amgen
Angiex, Inc.
Iambic Therapeutics, Inc
Pheon Therapeutics
Pheon Therapeutics
Conjupro Biotherapeutics, Inc.
AgonOx, Inc.
GlaxoSmithKline
Novartis
GlaxoSmithKline
Sairopa B.V.
Bristol-Myers Squibb
Elevation Oncology
AstraZeneca
Coherus Oncology, Inc.
St. Jude Children's Research Hospital
Tesaro, Inc.
Rondo Therapeutics
Turning Point Therapeutics, Inc.
HUYABIO International, LLC.
HUYABIO International, LLC.
National Institutes of Health Clinical Center (CC)
Pfizer
Sanofi
UNC Lineberger Comprehensive Cancer Center
Nurix Therapeutics, Inc.
Incyte Corporation
Pfizer
Exelixis
Context Therapeutics Inc.
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
Nuvation Bio Inc.
DEKA Biosciences